Does ATORVASTATIN Cause Upper respiratory tract infection? 133 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Upper respiratory tract infection have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.2% of all adverse event reports for ATORVASTATIN.
133
Reports of Upper respiratory tract infection with ATORVASTATIN
0.2%
of all ATORVASTATIN reports
7
Deaths
65
Hospitalizations
How Dangerous Is Upper respiratory tract infection From ATORVASTATIN?
Of the 133 reports, 7 (5.3%) resulted in death, 65 (48.9%) required hospitalization, and 4 (3.0%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which ATORVASTATIN Alternatives Have Lower Upper respiratory tract infection Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM